Atropine Sulfate Injection
Product Images NDC 71872-7316

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 71872-7316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7316.pdp (7316)

Atropine Sulfate Injection, USP, is a medication used for intravenous, intramuscular, subcutaneous, infraosseous, or endotracheal administration. Each mL contains 0.4 g of atropine sulfate, equivalent to 0.33 mg of atropine, along with benzyl alcohol, sodium chloride, and water for injection. The usual dosage should be determined based on the prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F) and discarded within 24 hours after initial use. It is manufactured by Hixma in Berkeley Heights, NJ, USA. The contact information for the distributor is provided as Medical Purchasing Solutions based in Scottsdale, AZ.*

FDA Label Image

73161.pdp (73161)

FDA Label Image

Atropine Sulfate Structural Formula (Atropine Sulfate Injection Usp Anda 1)

FDA Label Image

Representative Serialization Image (Atropine Sulfate Injection Usp Anda 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.